HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats
-
Add time:08/28/2019 Source:sciencedirect.com
Thrombin activates immunocompetent microglia and increases release of inflammatory cytokines under intracerebral hemorrhage (ICH) insults. Also, thrombin injection into the striatum evokes acute necrosis and delayed apoptosis of neurons. A nucleoprotein high-mobility group box 1 (HMGB1) that is released from necrotic cells has been suggested to behave like a cytokine and cause over-facilitation of immune functions. Here we examined the effect of glycyrrhizin, known as an inhibitor of HMGB1, on thrombin-induced injury in rat cortico-striatal slice cultures and in vivo rat ICH model. In slice cultures, thrombin-induced a drastic increase in propidium iodide fluorescence indicating necrotic cell death in the cortical region, and robust shrinkage of the striatal tissue. Glycyrrhizin (10–100 μM) attenuated thrombin-induced cortical injury in a concentration-dependent manner. The protective effect of glycyrrhizin was not mediated by glucocorticoid receptors or modulation of nitric oxide production, but was reversed by exogenous HMGB1 application. The injury induced by a high concentration of HMGB1 was suppressed by glycyrrhizin. In vivo, unilateral injection of type IV collagenase into rat striatum induced ICH associated with brain edema formation, contralateral paralysis and neuron death. Once daily intraperitoneal administration of glycyrrhizin attenuated ICH-induced edema in both the cortex and the basal ganglia, and improved behavioral performance of rats in forelimb placing. Moreover, glycyrrhizin partially but significantly ameliorated ICH-induced neuron loss inside hematoma. These findings suggest that an HMGB1 inhibitor glycyrrhizin is a potential candidate for a remedy for ICH.
We also recommend Trading Suppliers and Manufacturers of glycyrrhizin sulfate (cas 111196-54-4). Pls Click Website Link as below: cas 111196-54-4 suppliers
Prev:Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis
Next:Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Evaluation of surfactant assisted pressurized liquid extraction for the determination of glycyrrhizin and ephedrine in medicinal plants09/05/2019
- Effects of discontinuous administration of β-glucan and glycyrrhizin on the growth and immunity of white shrimp Litopenaeus vannamei09/04/2019
- Research letterPhysiological correlation between glycyrrhizin, glycyrrhizin-binding lipoxygenase and casein kinase II09/03/2019
- Pharmaceutical nanotechnologyGlycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery09/02/2019
- Recent Advances in TransplantationExperimental transplantationInhibition of High Mobility Group Box 1–Toll-Like Receptor-4 Signaling by Glycyrrhizin Contributes to the Attenuation of Cold Ischemic Injury of Liver in a Rat Model09/01/2019
- Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption08/31/2019
- Purification and characterization of a highly selective glycyrrhizin-hydrolyzing β-glucuronidase from Penicillium purpurogenum Li-308/30/2019
- Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance08/29/2019
- Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis08/27/2019


